Organonitrile 发表于 2025-3-25 06:53:56

Submitted on: 03 April 2009.
Revised on: 18 May 2009.
Accepted on: 22 June 2009.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Feedback 发表于 2025-3-25 10:41:06

http://reply.papertrans.cn/2/188/18702/18702-22.png

等待 发表于 2025-3-25 13:03:53

http://reply.papertrans.cn/2/188/18702/18702-23.png

languid 发表于 2025-3-25 18:14:41

Submitted on: 21 January 2007.
Revised on: 14 May 2007.
Accepted on: 06 June 2007.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Fibrinogen 发表于 2025-3-25 20:05:35

Submitted on: 16 June 2024.
Revised on: 01 October 2024.
Accepted on: 28 October 2024.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Acupressure 发表于 2025-3-26 02:49:21

http://reply.papertrans.cn/2/188/18702/18702-26.png

构成 发表于 2025-3-26 06:20:36

Submitted on: 06 March 2011.
Revised on: 04 May 2011.
Accepted on: 29 June 2011.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Oligarchy 发表于 2025-3-26 12:06:00

Submitted on: 05 January 2005.
Revised on: 13 February 2005.
Accepted on: 17 March 2005.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

反省 发表于 2025-3-26 14:19:54

http://reply.papertrans.cn/2/188/18702/18702-29.png

ALT 发表于 2025-3-26 19:29:10

Submitted on: 20 May 2000.
Revised on: 09 July 2000.
Accepted on: 05 August 2000.

___________________JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
页: 1 2 [3] 4
查看完整版本: SCIE期刊JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 2024/2025影响因子:3.144 (J PHARMACOL EXP THER) (0022-3565). (PH